Amanote Research
Register
Sign In
The Development of Drug Price Index for Each Health Care Sector in Taiwan
Value in Health
- United Kingdom
doi 10.1016/j.jval.2017.08.2775
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2017
Authors
W Lin
C Hsieh
YE Hsu
H Tan
C Lu
Publisher
Elsevier BV
Related search
Developing a Drug Price Reference Index in the Philippines
Journal of Pharmaceutical Policy and Practice
Toxicology
Pharmaceutics
Pharmacology
Health Policy
Health Care Exceptionalism? Performance and Allocation in the US Health Care Sector
American Economic Review
Economics
Econometrics
Data Hemorrhages in the Health-Care Sector
Lecture Notes in Computer Science
Computer Science
Theoretical Computer Science
European Ex-Factory Price Development for Global Pharmaceutical Companies in the Context of the International Price Reference (Ipr) Framework. Impact of the German Health Care Reform (Amnog) on the European Price Development for Innovative Pharmaceuticals
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Maintaining Standards in the Independent Sector of Health Care.
BMJ
Creating Price Indexes for Measuring Productivity in Mental Health Care
NBER/Frontiers in Health Policy Research
Common Health-Care Units in Industrial Parks in Taiwan
Sangyo eiseigaku zasshi = Journal of occupational health
Medicine
Environmental
Public Health
Toxicology
Occupational Health
The Public Sector in Health Care: Evolution or Dissolution?
Health Affairs
Medicine
Health Policy
Significance of Population Health Knowledge in the Education of the Undergraduate Workforce for Careers in the Health Care Sector
Frontiers in Public Health
Environmental
Public Health
Occupational Health
